References
- O'Driscoll W. G., Lindley G. R. Self-administration of tripelennamine by a narcotic addict. N. Engl. J. Med. 1957; 257: 376
- Jaffe R. B., Koschman E. B. Intravenous drug abuse, pulmonary, cardiac and vascular complications. Am. J. Roentgenol., Radium Ther. Nucl. Med. 1970; 109: 107
- Puro H. E., Wolf P. L., Skirgaudos J., Vasquez J. Experimental production of human ”Blue Velvet” and “Red Devil” lesions. J. Am. Med. Assoc. 1966; 197: 1100
- Wendt V. E., Puro H. E., Shapiro J., Mathew W., Wolf P. L. Angiothrombotic pulmonary hypertension in addicts. “Blue Velvet” addiction. J. Am. Med. Assoc. 1964; 188: 755
- Szwed J. J. Pulmonary angiothrombosis caused by “Blue Velvet” addiction. Ann. Intern. Med. 1970; 73: 771
- Arnett E. N., Battle W. E., Russo J. V., Roberts W. C. Intravenous injection of talc-containing drugs intended for oral use. A cause of pulmonary granulomatosis and pulmonary hypertension. Am. J. Med. 1976; 60: 711
- Burton J. F., Zawadski E. S., Wetherell H. R., Moy T. W. Mainliners and blue velvet. J. Forensic Sci. 1965; 10: 466
- Showalter C. V., Moore L. Abuse of pentazocine and tripelennamine. J. Am. Med. Assoc. 1978; 239: 1610
- Brogden R. N., Speight T. M., Avery G. S. Pentazocine: A review of its pharmacological properties, therapeutic efficacy and dependence liability. Drugs 1973; 5: 6
- Raskin N. N. Methadone for the pentazocine-dependent patient. N. Engl. J. Med. 1970; 283: 1349
- Wendel H. A. Management of pentazocine dependency. N. Engl. J. Med. 1971; 284: 504
- Ben Zur P. H. Management of pentazocine dependency. N. Engl. J. Med. 1971; 284: 504
- Lewis J. R. Use and misuse of pentazocine, a follow-up. J. Am. Med. Assoc. 1973; 225: 1530